Donor Serostatus Has an Impact on Cytomegalovirus-Specific Immunity, Cytomegaloviral Disease Incidence, and Survival in Seropositive Hematopoietic Cell Transplant Recipients-Reference-Cited by-同舟云学术

Donor Serostatus Has an Impact on Cytomegalovirus-Specific Immunity, Cytomegaloviral Disease Incidence, and Survival in Seropositive Hematopoietic Cell Transplant Recipients

Published:2011-04 Issue:4 Volume:17 Page:574-585
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Ugarte-Torres Alejandra,Hoegh-Petersen Mette,Liu Yiping,Zhou Feng,Williamson Tyler S.,Quinlan Diana,Sy Sarah,Roa Lina,Khan Faisal,Fonseca Kevin,Russell James A.,Storek Jan

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference50 articles.

1. Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients;Maury;Br J Haematol,2001

2. Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies;Boeckh;Biol Blood Marrow Transplant,2003

3. Cytomegalovirus infection after autologous bone marrow transplantation: occurrence of cytomegalovirus disease and effect on engraftment;Reusser;Blood,1990

4. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis;Li;Blood,1994

5. Lymphocyte responses after cytomegalovirus infection in bone marrow transplant recipients—a one-year follow-up;Ljungman;Transplantation,1985

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered HCMV‐infected APCs enable the identification of new immunodominant HLA‐restricted epitopes of anti‐HCMV T‐cell immunity;HLA;2024-06

2. Risk Factors Associated with Survival Following Ganciclovir Prophylaxis through Day +100 in Cytomegalovirus At-Risk Pediatric Allogeneic Stem Cell Transplantation Recipients: Development of Cytomegalovirus Viremia Associated with Significantly Decreased 1-Year Survival;Transplantation and Cellular Therapy;2024-01

3. Investigation of KIR/HLA relationship and other clinical variables after T-cell-replete haploidentical bone marrow transplantation in patients with acute myeloid leukemia (AML);BMC Immunology;2023-06-20

4. Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease;Cytotherapy;2022-12

5. Lack of both donor and recipient anti-EBV T cells in EBV seronegative recipients of grafts from seropositive donors;Bone Marrow Transplantation;2022-11-30